Diabetes Management

Introduction

• Diabetes management involves a comprehensive approach, including lifestyle modifications, medication, and monitoring, as recommended by the American Diabetes Association and the American College of Physicians 1, 2

Initiation of Therapy

• The American College of Physicians recommends initiating insulin therapy immediately if the patient presents with random blood glucose ≥250 mg/dL, HbA1c >9%, ketosis or diabetic ketoacidosis, or is markedly symptomatic, as stated by the Annals of Internal Medicine guidelines 2
• For newly diagnosed type 2 diabetes patients, initiate metformin therapy along with lifestyle interventions as first-line treatment, unless metformin is contraindicated or the patient presents with severe hyperglycemia, as recommended by the American Diabetes Association 1
• If patient presents with any of these conditions, start insulin therapy: random blood glucose ≥250 mg/dL, HbA1c >9%, ketosis or diabetic ketoacidosis, markedly symptomatic, or unclear distinction between type 1 and type 2 diabetes, as recommended by the American Diabetes Association and the American Academy of Pediatrics 1, 3
• Consider immediate insulin therapy for patients who are symptomatic, have HbA1c ≥10%, or have blood glucose levels ≥300 mg/dL, and show evidence of catabolism, as recommended by the American College of Physicians 4

Lifestyle Modifications

• Implement comprehensive lifestyle modifications simultaneously, including individualized medical nutrition therapy (MNT) by a registered dietitian, weight loss recommended for all overweight/obese individuals, and effective diet options such as low-carbohydrate, low-fat calorie-restricted, or Mediterranean diets, as recommended by the American Diabetes Association 1
• The American College of Physicians recommends referring patients to a registered dietitian for individualized medical nutrition therapy, with strong evidence and an A rating 2
• Recommend 150 minutes/week of moderate-intensity aerobic activity, spread over at least 3 days with no more than 2 consecutive days without exercise, and limit non-academic screen time to <2 hours daily, as recommended by the American Diabetes Association and the American Academy of Pediatrics 1, 3
• The American Academy of Pediatrics recommends 60 minutes of moderate-to-vigorous exercise daily for children and adolescents 2
• Nutrition counseling and physical activity programs should be implemented, with a goal of at least 60 minutes of moderate-to-vigorous exercise daily, as recommended by the American Heart Association 3, 5, 2
• Weight management should aim for 5% weight loss in overweight/obese patients, as recommended by the American Heart Association 2, 6

Monitoring and Follow-up

• The American College of Physicians recommends monitoring HbA1c every 3 months until target is achieved, then at least twice yearly, with a target HbA1c <7% for most adults 2
• Check HbA1c every 3 months, with a target HbA1c <7% for most adults, and consider more stringent goals (<6.5%) for selected patients or less stringent goals (<8%) for patients with history of severe hypoglycemia or advanced complications, as recommended by the American Diabetes Association 1
• Regular blood glucose monitoring is recommended for patients on insulin or medications with hypoglycemia risk, when initiating or changing treatment regimens, when treatment goals are not met, or during intercurrent illnesses, as recommended by the American Academy of Pediatrics 3
• Monitor for vitamin B12 deficiency with long-term metformin use, as recommended by the American College of Physicians 4
• Monitor renal function every 3-6 months with metformin and SGLT-2 inhibitors, and check vitamin B12 levels periodically with long-term metformin use, as recommended by the American Diabetes Association 7
• The American College of Physicians recommends screening for diabetes complications annually, including retinopathy, nephropathy, neuropathy, and cardiovascular risk assessment 2

Treatment Adjustment

• If glycemic targets are not met after 3 months of treatment, maximize metformin dose if tolerated, and add a second agent based on patient characteristics, as recommended by the American Diabetes Association 1
• The American College of Physicians recommends maximizing metformin dose if tolerated and adding a second agent based on patient characteristics if glycemic targets are not met after 3 months of treatment 2
• Consideration should be given to adding a SGLT-2 inhibitor or GLP-1 receptor agonist for cardiovascular benefits, according to the European Society of Cardiology 5
• Don't delay treatment intensification when glucose control is poor, as recommended by the American Diabetes Association, and avoid complex insulin regimens initially - optimize basal insulin before adding prandial insulin 7, 8, 9

Medication Options

• Metformin is the preferred initial pharmacologic agent for type 2 diabetes treatment due to its effectiveness, safety, low cost, and potential to reduce cardiovascular events and mortality, as recommended by the American College of Physicians and the American Diabetes Association 9, 10, 11, 12, 13, 6, 3
• The target dose of metformin is 2000 mg daily in divided doses, with periodic checks of vitamin B12 levels, especially in patients with anemia or peripheral neuropathy, and it is safe to use with estimated glomerular filtration rate as low as 30 mL/min/1.73 m², as recommended by the American College of Physicians 4
• The following table compares the effects of different medications:

11, 14

• The cost-effectiveness of different medications is as follows:

15

Insulin Therapy

• The American Diabetes Association recommends starting basal insulin with a dose of 0.1-0.2 units/kg/day and titrating every 2-3 days based on blood glucose monitoring 16
• Consider combination injectable therapy options, such as adding a single injection of rapid-acting insulin before the largest meal, adding a GLP-1 receptor agonist, switching to twice-daily premixed insulin, or using fixed-ratio combination products containing basal insulin plus a GLP-1 receptor agonist, if basal insulin is inadequate 4
• Premixed insulin (1-3 times daily) is an option for insulin initiation, according to the American Association of Clinical Endocrinologists 17
• Consider concentrated insulin products, such as U-500 regular insulin, U-300 glargine, U-200 degludec, and U-200 lispro, for patients requiring high doses, as recommended by the American College of Physicians 4

Hypoglycemia Risk

• The American College of Physicians recommends being vigilant in preventing hypoglycemia, especially in elderly patients or those with advanced disease 2
• Regular self-monitoring for patients taking insulin or medications with hypoglycemia risk, when initiating or changing treatment regimens, when treatment goals are not met, or during intercurrent illnesses, as recommended by the American Academy of Pediatrics 3

Patient Education

• Provide education at diagnosis and as needed thereafter, focusing on basic understanding of glucose monitoring, medications, diet, and hypoglycemia symptoms initially, and address psychosocial issues as part of diabetes self-management education (DSME), as recommended by the American Diabetes Association 1